149 related articles for article (PubMed ID: 22525678)
1. Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta.
Sung JY; Choi HC
Biochem Biophys Res Commun; 2012 May; 421(3):599-604. PubMed ID: 22525678
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine-induced AMP-activated protein kinase activation attenuates vasoconstriction through an LKB1-dependent mechanism in rat aorta.
Lee KY; Choi HC
Vascul Pharmacol; 2013; 59(3-4):96-102. PubMed ID: 23916920
[TBL] [Abstract][Full Text] [Related]
3. Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway.
Kim SG; Kim JR; Choi HC
J Med Food; 2018 Feb; 21(2):146-153. PubMed ID: 29035613
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction.
Hwang YJ; Cho DH
Biochem Biophys Res Commun; 2020 Apr; 524(4):853-860. PubMed ID: 32046856
[TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase.
Horman S; Morel N; Vertommen D; Hussain N; Neumann D; Beauloye C; El Najjar N; Forcet C; Viollet B; Walsh MP; Hue L; Rider MH
J Biol Chem; 2008 Jul; 283(27):18505-12. PubMed ID: 18426792
[TBL] [Abstract][Full Text] [Related]
6. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
Sung JY; Choi HC
Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
[TBL] [Abstract][Full Text] [Related]
8. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
9. Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate.
Taylor EB; Ellingson WJ; Lamb JD; Chesser DG; Compton CL; Winder WW
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E661-9. PubMed ID: 16278246
[TBL] [Abstract][Full Text] [Related]
10. Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues.
Kojima K; Motoshima H; Tsutsumi A; Igata M; Matsumura T; Kondo T; Kawashima J; Ichinose K; Furukawa N; Inukai K; Katayama S; Goldstein BJ; Nishikawa T; Tsuruzoe K; Araki E
Biochem Biophys Res Commun; 2008 Nov; 376(2):434-8. PubMed ID: 18789895
[TBL] [Abstract][Full Text] [Related]
11. A role for Rho kinase in vascular contraction evoked by sodium fluoride.
Jeon SB; Jin F; Kim JI; Kim SH; Suk K; Chae SC; Jun JE; Park WH; Kim IK
Biochem Biophys Res Commun; 2006 Apr; 343(1):27-33. PubMed ID: 16527249
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice.
Wang S; Liang B; Viollet B; Zou MH
Hypertension; 2011 May; 57(5):1010-7. PubMed ID: 21464390
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle.
Tsai MH; Jiang MJ
Life Sci; 2005 Jan; 76(8):877-88. PubMed ID: 15589965
[TBL] [Abstract][Full Text] [Related]
15. Effects of 3',4'-dihydroxyflavonol on vascular contractions of rat aortic rings.
Song MJ; Baek I; Seo M; Kim SH; Suk K; Woodman OL; Williams SJ; Kim IK
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):803-10. PubMed ID: 20374259
[TBL] [Abstract][Full Text] [Related]
16. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
Sauro MD; Thomas B
J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.
Shimomura E; Shiraishi M; Iwanaga T; Seto M; Sasaki Y; Ikeda M; Ito K
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):414-22. PubMed ID: 15459803
[TBL] [Abstract][Full Text] [Related]
19. Regulation of contractile activity in vascular smooth muscle by protein kinases.
Silver PJ
Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
[TBL] [Abstract][Full Text] [Related]
20. Effects of a myosin light chain kinase inhibitor, wortmannin, on cytoplasmic Ca2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle.
Takayama M; Ozaki H; Karaki H
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):120-7. PubMed ID: 8857588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
